Dr. Steven Hollon, professor of psychology at Vanderbilt University and a leading researcher in psychotherapy outcomes, notes that the most common comparison — CBT vs. medication — yields a critical finding: CBT produces equivalent short-term improvement but 50-60% lower relapse rates at two-year follow-up (per a 2019 JAMA Psychiatry meta-analysis, n=2,184). Three modalities stand out for evidence breadth: Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), and Eye Movement Desensitization and Reprocessing (EMDR). Each was developed for specific conditions.
CBT operates on the cognitive model: thoughts influence emotions, which influence behavior. It has the largest evidence base in psychotherapy, with documented efficacy for depression, anxiety disorders, insomnia, chronic pain, and eating disorders. Typically 12-20 sessions.
DBT's four skill modules — mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness — address the core deficit in emotional dysregulation. It has since shown efficacy for substance use disorders and eating disorders, with a 2020 Clinical Psychology Review meta-analysis (k=18, n=1,187) confirming moderate-to-large effect sizes across conditions.
EMDR was developed for PTSD by Dr. Francine Shapiro (Mental Research Institute). Patients process traumatic memories while engaging in bilateral stimulation. A 2020 Psychological Medicine meta-analysis (k=11, n=650) by Dr. Christopher Lee at the University of Western Australia found EMDR equally effective as trauma-focused CBT for PTSD, with evidence suggesting faster response — median 6-8 sessions versus 12-16 for CBT.
The choice should be condition-driven. Anxiety and depression without trauma: CBT. PTSD: EMDR or trauma-focused CBT. Emotional dysregulation or borderline traits: DBT.
The therapist matters more than the modality. Dr. John Norcross, professor of psychology at the University of Scranton, analyzed 295 studies for the APA Division 29 Task Force and concluded that therapeutic alliance predicts outcomes as strongly as the specific treatment approach. Training in an evidence-based modality is the entry criterion; personal fit determines the ceiling.
Dr. Bruce Wampold, professor emeritus at the University of Wisconsin-Madison and author of The Great Psychotherapy Debate, analyzed 277 psychotherapy trials and found that the specific technique accounts for only 1-5% of variance in outcomes, while the therapeutic alliance accounts for 5-9%. His finding does not mean technique is irrelevant — it means that a poorly matched therapist using the "right" modality will be outperformed by a well-matched therapist using a less-targeted approach. The practical implication: find a licensed therapist trained in an evidence-based modality, then evaluate the relationship at session three. If you don't feel heard and respected, switch therapists rather than switching modalities.
Cost and access vary significantly. CBT has the broadest availability and insurance coverage. Online CBT platforms (validated in a 2021 Lancet Psychiatry meta-analysis, k=53, n=13,000+) produce 70-80% of the effect size of in-person therapy for mild-to-moderate anxiety and depression. DBT requires a full program (individual therapy plus skills group), which limits availability and increases cost to $200-400/week in most markets. EMDR typically requires 6-12 sessions for single-incident trauma, making it the most cost-effective option for straightforward PTSD.